Prevalence of autoimmune diabetes among Aboriginal Australians: The Fremantle Diabetes Study Phase II

Authors

Timothy M.E. Davis
Christine S. Bundell
Stephen Chubb
Daniel McAullay, Edith Cowan UniversityFollow
Wendy A. Davis

Author Identifier

Daniel McAullay: https://orcid.org/0000-0002-0651-899X

Document Type

Journal Article

Publication Title

Internal Medicine Journal

Volume

55

Issue

4

First Page

659

Last Page

663

PubMed ID

40099758

Publisher

Wiley

School

Kurongkurl Katitjin

Funders

Medical Research Future Fund Practitioner Fellowship (1154192)

Comments

Davis, T. M., Bundell, C. S., Chubb, S. A. P., McAullay, D., & Davis, W. A. (2025). Prevalence of autoimmune diabetes among Aboriginal Australians: The Fremantle Diabetes Study Phase II. Internal Medicine Journal, 55(4), 659-663. https://doi.org/10.1111/imj.70029

Abstract

The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.

DOI

10.1111/imj.70029

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.